Perseus Proteomics Inc. (TYO:4882)
Japan
· Delayed Price · Currency is JPY 288.00
+55.00 (23.61%)
At close: Mar 9, 2026
Perseus Proteomics Market Cap
Perseus Proteomics has a market cap or net worth of 4.25 billion as of March 9, 2026. Its market cap has decreased by -52.37% in one year.
Market Cap
4.25B
Enterprise Value
3.01B
Revenue
140.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
288.00
Market Cap Chart
Since June 22, 2021, Perseus Proteomics's market cap has decreased from 10.12B to 4.25B, a decrease of -58.03%. That is a compound annual growth rate of -16.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 4.25B | 28.57% |
| Dec 30, 2025 | 3.30B | -60.12% |
| Dec 30, 2024 | 8.28B | 13.70% |
| Dec 29, 2023 | 7.29B | 97.33% |
| Dec 30, 2022 | 3.69B | -20.91% |
| Dec 30, 2021 | 4.67B | -53.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| JCR Pharmaceuticals | 76.00B |
| Santen Pharmaceutical | 520.79B |
| Kyowa Kirin | 1,178.63B |
| Ono Pharmaceutical | 1,184.64B |
| Astellas Pharma | 4,306.08B |
| Daiichi Sankyo Company | 5,297.22B |
| Otsuka Holdings | 5,309.85B |
| Chugai Pharmaceutical | 15.78T |